JP2014517308A5 - - Google Patents

Info

Publication number
JP2014517308A5
JP2014517308A5 JP2014513942A JP2014513942A JP2014517308A5 JP 2014517308 A5 JP2014517308 A5 JP 2014517308A5 JP 2014513942 A JP2014513942 A JP 2014513942A JP 2014513942 A JP2014513942 A JP 2014513942A JP 2014517308 A5 JP2014517308 A5 JP 2014517308A5
Authority
JP
Japan
Prior art keywords
biomarker
subject
level
determining
sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014513942A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014517308A (ja
JP6120832B2 (ja
Filing date
Publication date
Priority claimed from EP11004597A external-priority patent/EP2533051A1/en
Application filed filed Critical
Publication of JP2014517308A publication Critical patent/JP2014517308A/ja
Publication of JP2014517308A5 publication Critical patent/JP2014517308A5/ja
Application granted granted Critical
Publication of JP6120832B2 publication Critical patent/JP6120832B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014513942A 2011-06-06 2012-06-06 ゴーシェ病の診断のための方法 Expired - Fee Related JP6120832B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP11004597.8 2011-06-06
EP11004597A EP2533051A1 (en) 2011-06-06 2011-06-06 Method for the diagnosis of Gaucher's disease
PCT/EP2012/002409 WO2012167925A1 (en) 2011-06-06 2012-06-06 Method for the diagnosis of gaucher's disease

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017062025A Division JP6514256B2 (ja) 2011-06-06 2017-03-28 ゴーシェ病の診断のための方法

Publications (3)

Publication Number Publication Date
JP2014517308A JP2014517308A (ja) 2014-07-17
JP2014517308A5 true JP2014517308A5 (https=) 2015-07-23
JP6120832B2 JP6120832B2 (ja) 2017-04-26

Family

ID=44652046

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2014513942A Expired - Fee Related JP6120832B2 (ja) 2011-06-06 2012-06-06 ゴーシェ病の診断のための方法
JP2017062025A Expired - Fee Related JP6514256B2 (ja) 2011-06-06 2017-03-28 ゴーシェ病の診断のための方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2017062025A Expired - Fee Related JP6514256B2 (ja) 2011-06-06 2017-03-28 ゴーシェ病の診断のための方法

Country Status (15)

Country Link
US (3) US10859580B2 (https=)
EP (4) EP2533051A1 (https=)
JP (2) JP6120832B2 (https=)
CN (1) CN103582818B (https=)
AU (2) AU2012266768B2 (https=)
BR (1) BR112013031431B1 (https=)
CA (1) CA2837609C (https=)
DK (2) DK3318881T3 (https=)
ES (2) ES2659753T3 (https=)
IL (2) IL229607B (https=)
NO (1) NO2718725T3 (https=)
PL (2) PL3318881T3 (https=)
PT (2) PT3318881T (https=)
RU (1) RU2666952C2 (https=)
WO (1) WO2012167925A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2893609A1 (en) * 2012-12-11 2014-06-19 Centogene Ag Method for the diagnosis of metachromatic leukodystrophy
EP3105588A1 (en) * 2014-02-11 2016-12-21 Yeda Research and Development Co., Ltd. Marker of neuropathic gaucher's disease and methods of use thereof
CN105463085A (zh) * 2015-12-11 2016-04-06 上海新培晶医学检验所有限公司 一种检测戈谢病gba基因突变的试剂盒及其检测方法
EP3264092A1 (en) 2016-07-01 2018-01-03 Centogene AG Use of lyso-gb1 as druggable target
RU2629626C1 (ru) * 2016-10-05 2017-08-30 Федеральное государственное автономное учреждение "Научный центр здоровья детей" Министерства здравоохранения Российской Федерации (ФГАУ "НЦЗД" Минздрава России) Способ оценки эффективности лечения болезни Гоше у детей
US12246037B2 (en) 2020-12-08 2025-03-11 Todd Frank Ovokaitys Methods and systems for increased production of stem cells
IL317112A (en) * 2022-06-01 2025-01-01 Univ Antwerpen Method for detecting biomarkers of lysosomal storage disease and kits for performing the method
WO2024211616A1 (en) * 2023-04-04 2024-10-10 Ovokaitys Todd Frank Methods and systems for improved therapies of genetic diseases using photo-activated allogenic stem cells

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5236838A (en) 1988-12-23 1993-08-17 Genzyme Corporation Enzymatically active recombinant glucocerebrosidase
UA63743A (en) * 2003-06-09 2004-01-15 Kyiv P Shupyk Medical Academy Method for diagnosing gaucher disease
EP1528056A1 (en) 2003-10-29 2005-05-04 Academisch Ziekenhuis bij de Universiteit van Amsterdam Deoxynojirimycin analogues and their uses as glucosylceramidase inhibitors
AU2006254796B2 (en) 2005-06-08 2012-08-16 Amicus Therapeutics, Inc. Treatment of CNS disorders associated with mutations in genes encoding lysosomal enzymes
WO2007150064A2 (en) * 2006-06-23 2007-12-27 Amicus Therapeutics, Inc. METHOD FOR THE TREATMENT OF NEUROLOGICAL DISORDERS BY ENHANCING THE ACTIVITY OF β-GLUCOCEREBROSIDASE
JP5586453B2 (ja) * 2007-04-13 2014-09-10 アミカス セラピューティックス インコーポレイテッド 特異的薬理シャペロンによるゴーシェ病の治療および代理マーカーを用いた治療の監視
MX2009011473A (es) * 2007-04-26 2010-01-18 Amicus Therapeutics Inc Regimenes de dosificacion para el tratamiento de enfermedades por almacenamiento lisosomal que utilizan chaperonas farmacologicas.
EP2154969B1 (en) * 2007-05-16 2015-11-18 The Brigham and Women's Hospital, Inc. Treatment of synucleinopathies
GB2480159A (en) * 2008-11-14 2011-11-09 Parkinson S Inst Compositions and methods for the treatment of altered a-synuclein function

Similar Documents

Publication Publication Date Title
JP2014517308A5 (https=)
JP7042279B2 (ja) 有害事象を示すマーカーとしてのproadm
WO2010002911A3 (en) Methods and materials for monitoring myeloma using quantitative mass spetrometry
RU2013158667A (ru) Способ диагностики болезни гоше
BR112014006741A2 (pt) método para monitorização, diagnóstico e/ou prognóstico de lesão renal aguda no estágio inicial
JP2017184729A5 (https=)
JP2016536598A (ja) 神経疾患のバイオマーカーを同定するための方法および神経疾患の診断
Dalsgaard et al. Toxicological screening of basic drugs in whole blood using UPLC‐TOF‐MS
WO2018029214A1 (en) Histones and/or proadm as markers indicating an adverse event
Heikman et al. Urine naloxone concentration at different phases of buprenorphine maintenance treatment
JP7179356B2 (ja) 代謝物分析を利用したベーチェット病の診断方法
WO2016051020A1 (en) Methods for detecting ovarian cancer
JP2018004657A5 (https=)
WO2018022866A1 (en) Diagnostic methods, therapeutic agents and uses thereof
Lin et al. An UHPLC–MS/MS method for simultaneous quantification of human amyloid beta peptides Aβ1-38, Aβ1-40 and Aβ1-42 in cerebrospinal fluid using micro-elution solid phase extraction
JP2024096748A (ja) アルファ-シヌクレイン病のアッセイ、方法、及び治療
WO2013025759A1 (en) Peptide and protein biomarkers for type 1 diabetes mellitus
TWI822802B (zh) 腎病變蛋白生物標記及其應用
JP2014505254A5 (https=)
JP5695075B2 (ja) アルツハイマー病又は軽度認知症のバイオマーカー
JP2013527427A5 (https=)
JP5524241B2 (ja) 腎症と関連するバイオマーカー
JP2016522406A5 (https=)
Syslová et al. Immunomagnetic molecular probe with UHPLC–MS/MS: A promising way for reliable bronchial asthma diagnostics based on quantification of cysteinyl leukotrienes
WO2003101176A3 (en) Method, composition and kit for antigenic binding of norwalk-like viruses